National Institute on Drug Abuse Clinical Trial Network: New England Consortium Node
国家药物滥用研究所临床试验网络:新英格兰联盟节点
基本信息
- 批准号:10573954
- 负责人:
- 金额:$ 10.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-30 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAddressAftercareAgeAttitudeBehavioralBlack PopulationsBlack raceBuprenorphineCessation of lifeClinical Trials NetworkData AnalysesDevelopmentDiscriminationEmergency Department patientEmergency Department-based InterventionEmergency MedicineEmergency department visitEnrollmentEthnic OriginFaceFormulationFutureGoalsHealth Services ResearchHealthcare SystemsHelping to End Addiction Long-termIndividualInjectableInstitutionInterviewKnowledgeLatinoLatino PopulationLinkLocationMajor Depressive DisorderMedicineMethadoneNational Institute of Drug AbuseNew EnglandOpioidParticipantPatientsPatternPerceptionPharmaceutical PreparationsPopulationPositioning AttributePublic HealthRaceRandomized Clinical TrialsResearchResearch MethodologyRuralSeriesServicesSocial PoliciesStimulantStructureSuboxoneSurvivorsTreatment outcomeUnited States National Institutes of HealthValidationaddictionbasebuprenorphine treatmentcomparative efficacydepressive symptomsimprovedinnovationnovelopioid epidemicopioid mortalityopioid overdoseopioid use disorderoverdose deathpolysubstance useprimary outcomeracial and ethnicracial and ethnic disparitiessocial stigmasuburb
项目摘要
PROJECT SUMMARY
In recent years there has been a marked surge in opioid overdose deaths across Black and Latino populations.
Addiction treatment, which includes medications for opioid use disorder (MOUD) such as buprenorphine,
decreases fatal opioid overdoses. Yet Black and Latino individuals face substantial disparities in access to
MOUD and addiction treatment. The emergency department (ED) represents an emerging setting to initiate
MOUD and provide linkage to ongoing addiction treatment to Black and Latino individuals with untreated opioid
use disorder (OUD). However, little is known about the barriers and facilitators that Black and Latino individuals
encounter to engage in addiction treatment subsequent to an ED visit. Moreover, less is known about the
differences in ED presentation for opioid overdose, polysubstance use, major depressive disorder, and stigma
within these populations. Filling these knowledge gaps are important because opioid overdose, polysubstance
use, major depressive disorder, and stigma have each been linked to worse treatment outcomes. Further,
eliciting barriers and facilitators can inform future ED-based interventions to enhance engagement in addiction
treatment among Black and Latino individuals with untreated OUD. The goal of this proposal is to evaluate
disparities in access to addiction treatment and elicit potential targets for ED-based interventions that enhance
engagement in addiction treatment among Black and Latino populations. The specific aims are to: 1) conduct
a qualitative study focusing on patterns of barriers and facilitators to engaging in addiction treatment among
Black, Latino, and non-Latino White patients receiving ED-initiated buprenorphine treatment with a referral for
continuation of OUD treatment outside of the ED and 2) evaluate differences among Black, Latino, and non-
Latino White ED patients with untreated OUD on factors previously identified as predictors of worse treatment
outcome, including opioid overdose, polysubstance use, major depressive disorder, and stigma, using
supplemental analyses of data collected in CTN 0099. To accomplish this, we will conduct both semi-structured
individual interviews of Black, Latino, and non-Latino White participants enrolled in CTN 0099 after they have
completed their final 30-day assessments and supplemental analyses from data collected in CTN 0099. Study
findings will inform the development of an ED-based intervention that enhances engagement in addiction
treatment among Black and Latino populations subsequent to ED visit.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gail D'Onofrio其他文献
Gail D'Onofrio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gail D'Onofrio', 18)}}的其他基金
Yale-METRO Metropolitan Emergency Trial netwoRK to advance patient Outcomes
耶鲁大学-METRO 大都会紧急试验网络可改善患者的治疗效果
- 批准号:
10552382 - 财政年份:2023
- 资助金额:
$ 10.55万 - 项目类别:
Clinical Trials Network: Admin Supplement: Integrating MOUD with BUP in Non-medical Community Settings
临床试验网络:管理补充:在非医疗社区环境中将 MOUD 与 BUP 集成
- 批准号:
10801347 - 财政年份:2023
- 资助金额:
$ 10.55万 - 项目类别:
Standard versus High Dose ED-Initiated Buprenorphine Induction
标准剂量与高剂量 ED 引发的丁丙诺啡诱导
- 批准号:
10801950 - 财政年份:2023
- 资助金额:
$ 10.55万 - 项目类别:
Clinical Trials Network New England Consortium Node: Admin Supplement CTN0131
临床试验网络新英格兰联盟节点:管理补充 CTN0131
- 批准号:
10655837 - 财政年份:2022
- 资助金额:
$ 10.55万 - 项目类别:
National Institute on Drug Abuse Clinical Trial Network: New England Consortium Node
国家药物滥用研究所临床试验网络:新英格兰联盟节点
- 批准号:
10684501 - 财政年份:2022
- 资助金额:
$ 10.55万 - 项目类别:
Clinical Trials Network New England Consortium Node: Admin Supplement CTN0126
临床试验网络新英格兰联盟节点:管理补充 CTN0126
- 批准号:
10655828 - 财政年份:2022
- 资助金额:
$ 10.55万 - 项目类别:
The National Drug Abuse Clinical Trials Network: New England Consortium Node
国家药物滥用临床试验网络:新英格兰联盟节点
- 批准号:
10450554 - 财政年份:2021
- 资助金额:
$ 10.55万 - 项目类别:
The National Drug Abuse Clinical Trials Network: New England Consortium Node
国家药物滥用临床试验网络:新英格兰联盟节点
- 批准号:
10442107 - 财政年份:2021
- 资助金额:
$ 10.55万 - 项目类别:
The National Drug Abuse Clinical Trials Network: New England Consortium Node
国家药物滥用临床试验网络:新英格兰联盟节点
- 批准号:
10451986 - 财政年份:2021
- 资助金额:
$ 10.55万 - 项目类别:
EMBED: Pragmatic trial of user-centered clinical decision support to implement EMergency department-initiated BuprenorphinE for opioid use Disorder
EMBED:以用户为中心的临床决策支持的实用试验,以实施急诊部门发起的丁丙诺啡E治疗阿片类药物使用障碍
- 批准号:
9928151 - 财政年份:2018
- 资助金额:
$ 10.55万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 10.55万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 10.55万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 10.55万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 10.55万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 10.55万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 10.55万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 10.55万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 10.55万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 10.55万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 10.55万 - 项目类别:
Research Grant